About us

Hyloris Pharmaceuticals is a company founded in December 2013 and based in Liège (Belgium).

We are focused on 505(b)(2) (New Drug Application) and hybrid medicinal products for the U.S. and European markets. Our portfolio of development projects includes rare and orphan products (inherited bleeding disorders, arrhythmia disorders and oncology), Ready-To-Use and Pre-Filled-Syringe products spanning a wide range of therapeutic indications and dosage forms.

Our team has a significant industry experience, each of us with a background of 20-28 years in business development, operations, product development, clinical and regulatory focus areas. 

 

 

Comments are closed